MOUWASAT

Mouwasat Medical Services Co.

4002StocksTadawulHealthcare

Financials

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	14.22B	13.33B	17.02B	22.36B	20.90B
Market Cap Growth	-14.9%	-21.7%	-23.9%	+7.0%	+20.3%
Enterprise Value	14.85B	13.97B	17.69B	23.17B	21.90B
Last Close Price	71.10	66.65	81.75	105.71	97.61
Valuation Multiples
Forward PE (Next 12M Est.)	17.03	16.67	20.61	30.17	29.27
PE Ratio	17.30	16.22	26.36	34.00	34.87
PEG Ratio	—	1.67	1.32	2.22	2.25
PS Ratio	4.41	4.14	5.91	8.27	8.95
PB Ratio	3.63	3.42	4.58	6.53	6.79
P/TBV Ratio	3.81	3.60	4.82	6.90	7.23
P/FCF Ratio	18.51	11.32	20.57	41.66	50.42
P/OCF Ratio	12.07	11.32	13.55	27.48	29.55
EV/Sales Ratio	4.61	4.34	6.15	8.57	9.38
EV/EBITDA Ratio	13.27	12.73	18.52	23.78	25.61
EV/EBIT Ratio	16.90	16.37	24.45	30.63	32.57
EV/FCF Ratio	19.34	11.86	21.38	43.18	52.84
Leverage & Capital
Debt / Equity Ratio	0.27	0.27	0.21	0.23	0.29
Debt / EBITDA Ratio	0.97	0.97	0.79	0.81	1.04
Debt / FCF Ratio	0.91	0.91	0.92	1.47	2.15
Net Debt / Equity Ratio	0.13	0.13	0.07	0.19	0.21
Net Debt / EBITDA Ratio	0.45	0.45	0.26	0.66	0.75
Net Debt / FCF Ratio	0.42	0.42	0.30	1.19	1.54
Efficiency & Liquidity
Asset Turnover	—	—	0.56	0.56	0.54
Inventory Turnover	—	—	7.52	7.04	6.40
Quick Ratio	—	—	1.64	1.58	1.69
Current Ratio	—	—	1.99	1.95	2.05
Returns & Yields
Return on Equity (ROE)	+21.6%	+21.6%	+18.8%	+21.2%	+21.9%
Return on Assets (ROA)	—	—	+8.7%	+9.8%	+9.6%
Return on Invested Capital (ROIC)	+18.7%	+19.7%	+17.1%	+18.4%	+18.4%
Return on Capital Employed (ROCE)	—	—	+16.0%	+18.3%	+17.3%
Earnings Yield	+5.8%	+6.2%	+3.8%	+2.9%	+2.9%
FCF Yield	+5.4%	+8.8%	+4.9%	+2.4%	+2.0%
Dividend Yield	+3.2%	—	+2.4%	+1.7%	+1.5%
Payout Ratio	+73.0%	—	+54.2%	+45.6%	+45.9%
Buyback Yield / Dilution	0.0%	0.0%	—	—	—
Total Shareholder Return	+3.2%	0.0%	+2.4%	+1.7%	+1.5%

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Ratios

1-5

	CurrentMar 10, 2026	2025Dec 31, 2025	2024Dec 31, 2024	2023Dec 31, 2023	2022Dec 31, 2022
Market & Price
Market Capitalization	14.22B	13.33B	17.02B	22.36B	20.90B
Market Cap Growth	-14.9%	-21.7%	-23.9%	+7.0%	+20.3%
Enterprise Value	14.85B	13.97B	17.69B	23.17B	21.90B
Last Close Price	71.10	66.65	81.75	105.71	97.61
Valuation Multiples
Forward PE (Next 12M Est.)	17.03	16.67	20.61	30.17	29.27
PE Ratio	17.30	16.22	26.36	34.00	34.87
PEG Ratio	—	1.67	1.32	2.22	2.25
PS Ratio	4.41	4.14	5.91	8.27	8.95
PB Ratio	3.63	3.42	4.58	6.53	6.79
P/TBV Ratio	3.81	3.60	4.82	6.90	7.23
P/FCF Ratio	18.51	11.32	20.57	41.66	50.42
P/OCF Ratio	12.07	11.32	13.55	27.48	29.55
EV/Sales Ratio	4.61	4.34	6.15	8.57	9.38
EV/EBITDA Ratio	13.27	12.73	18.52	23.78	25.61
EV/EBIT Ratio	16.90	16.37	24.45	30.63	32.57
EV/FCF Ratio	19.34	11.86	21.38	43.18	52.84
Leverage & Capital
Debt / Equity Ratio	0.27	0.27	0.21	0.23	0.29
Debt / EBITDA Ratio	0.97	0.97	0.79	0.81	1.04
Debt / FCF Ratio	0.91	0.91	0.92	1.47	2.15
Net Debt / Equity Ratio	0.13	0.13	0.07	0.19	0.21
Net Debt / EBITDA Ratio	0.45	0.45	0.26	0.66	0.75
Net Debt / FCF Ratio	0.42	0.42	0.30	1.19	1.54
Efficiency & Liquidity
Asset Turnover	—	—	0.56	0.56	0.54
Inventory Turnover	—	—	7.52	7.04	6.40
Quick Ratio	—	—	1.64	1.58	1.69
Current Ratio	—	—	1.99	1.95	2.05
Returns & Yields
Return on Equity (ROE)	+21.6%	+21.6%	+18.8%	+21.2%	+21.9%
Return on Assets (ROA)	—	—	+8.7%	+9.8%	+9.6%
Return on Invested Capital (ROIC)	+18.7%	+19.7%	+17.1%	+18.4%	+18.4%
Return on Capital Employed (ROCE)	—	—	+16.0%	+18.3%	+17.3%
Earnings Yield	+5.8%	+6.2%	+3.8%	+2.9%	+2.9%
FCF Yield	+5.4%	+8.8%	+4.9%	+2.4%	+2.0%
Dividend Yield	+3.2%	—	+2.4%	+1.7%	+1.5%
Payout Ratio	+73.0%	—	+54.2%	+45.6%	+45.9%
Buyback Yield / Dilution	0.0%	0.0%	—	—	—
Total Shareholder Return	+3.2%	0.0%	+2.4%	+1.7%	+1.5%